We are pleased to inform our customers and partners that 5-Fluorouracil (5FU) is available again with immediate effect. Through our consistent work on a stable, resilient supply chain and close coordination with the responsible authorities, the supply situation has been successfully secured. The recently granted approval of the corresponding variation by the BfArM confirms the quality and reliability of our product and marks the final step for the release of stock.
Bendalis GmbH is relying on – as established in our supply chain strategy – European manufacturing sites, duplicate drug reference paths and the highest quality standards, in order to sustainable availability to ensure essential medicines like 5FU are available for patients.
For our customers and partners, this means: Scheduled supply, maximum security and direct availability – reliable, quality-assured, and „Made in Europe“.